Skip to main content

Table 3 The model’s results considering the cumulative effect of new and generic drugs

From: New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)

   2015 2016 2017 2018 2019
Number of patients 94,727 99,205 103,893 108,804 113,946
No new and generic drugs scenario Total ART cost (€) 764,962,036 789,011,152 813,397,033 838,115,496 863,159,214
Per capita ART cost (€) 8,075 7,953 7,829 7,703 7,575
New and generic drugs scenario Total ART cost (€) 760,408,704 772,152,627 794,021,079 787,013,681 752,848,759
Per capita ART cost (€) 8,027 7,783 7,643 7,233 6,607
Δ in total cost (€) −4,553,331 −16,858,525 −19,375,954 −51,101,815 −110,310,454
% Δ in total cost −0.6 % −2.1 % −2.4 % −6.1 % −12.78 %